PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
October 5, 2010Hypertension448 citations

Management of High Blood Pressure in Blacks

View Full Paper
JFJohn M. FlackDSDomenic A. SicaGBGeorge L. Bakris

Key Result

The updated consensus statement on hypertension management in blacks recommends target blood pressures of <135/85 mm Hg for primary prevention and <130/80 mm Hg for secondary prevention.

Structured PICO

What are the optimal blood pressure targets and pharmacological treatment strategies for managing hypertension in Black patients?

P
Population
Blacks with hypertension, categorized into primary prevention (no target organ damage or cardiovascular disease) and secondary prevention (target organ damage, preclinical cardiovascular disease, and/or history of cardiovascular disease).
I
Intervention
Blood pressure management with specific targets (<135/85 mm Hg for primary prevention, <130/80 mm Hg for secondary prevention) and pharmacological strategies (diuretic or calcium channel blocker monotherapy if ≤10 mm Hg above target; calcium channel blocker or thiazide diuretic plus a renin-angiotensin system blocker if >15/10 mm Hg above target).

This consensus statement provides updated, more stringent blood pressure targets and specific pharmacological recommendations for managing hypertension in Black patients.

Abstract

Since the first International Society on Hypertension in Blacks consensus statement on the "Management of High Blood Pressure in African American" in 2003, data from additional clinical trials have become available. We reviewed hypertension and cardiovascular disease prevention and treatment guidelines, pharmacological hypertension clinical end point trials, and blood pressure-lowering trials in blacks. Selected trials without significant black representation were considered. In this update, blacks with hypertension are divided into 2 risk strata, primary prevention, where elevated blood pressure without target organ damage, preclinical cardiovascular disease, or overt cardiovascular disease for whom blood pressure consistently 15/10 mm Hg above target, 2-drug therapy is recommended, with either a calcium channel blocker plus a renin-angiotensin system blocker or, alternatively, in edematous and/or volume-overload states, with a thiazide diuretic plus a renin-angiotensin system blocker. Effective multidrug therapeutic combinations through 4 drugs are described. Comprehensive lifestyle modifications should be initiated in blacks when blood pressure is ≥115/75 mm Hg. The updated International Society on Hypertension in Blacks consensus statement on hypertension management in blacks lowers the minimum target blood pressure level for the lowest-risk blacks, emphasizes effective multidrug regimens, and de-emphasizes monotherapy.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Flack et al. (2010) conducted a review in High blood pressure in Blacks. Updated hypertension management guidelines was evaluated. The updated consensus statement on hypertension management in blacks recommends target blood pressures of <135/85 mm Hg for primary prevention and <130/80 mm Hg for secondary prevention.

synapsesocial.com/papers/6a09de4659b902245b4632f4https://doi.org/10.1161/hypertensionaha.110.152892
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 391998 · 1,395 citations
  2. 2Ethnic Differences in Sleep Quality Accompany Ethnic Differences in Night-time Blood Pressure Dipping2007 · 42 citations
  3. 3State of Disparities in Cardiovascular Health in the United States2005 · 1,221 citations
  4. 4Ethnic/Racial Variations in Blood Pressure Awareness, Treatment, and Control2007 · 95 citations
  5. 5Clinical Outcomes by Race in Hypertensive Patients With and Without the Metabolic Syndrome Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)2008 · 113 citations